D.E. Shaw & Co
APGE icon

D.E. Shaw & Co’s Apogee Therapeutics APGE Stock Holding History

D.E. Shaw & Co’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Sell
58,835
-4,415
-7% -$321K ﹤0.01% 2183
2025
Q4 		$4.77M Sell
63,250
-37,320
-37% -$2.35M ﹤0.01% 2345
2025
Q3 		$4M Sell
100,570
-93,958
-48% -$3.59M ﹤0.01% 2415
2025
Q2 		$8.45M Buy
194,528
+185,752
+2,117% +$7.07M 0.01% 1626
2025
Q1 		$328K Sell
8,776
-1,037
-11% -$40.1K ﹤0.01% 3729
2024
Q4 		$445K Sell
9,813
-39,849
-80% -$2.03M ﹤0.01% 3689
2024
Q3 		$2.92M Sell
49,662
-2,364
-5% -$113K ﹤0.01% 2402
2024
Q2 		$2.05M Buy
+52,026
New +$2.53M ﹤0.01% 2638

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return